BNP Paribas Asset Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $47.1M | Sell |
714,344
-113,519
| -14% | -$7.21M | 0.05% | 328 |
|
|
2025
Q4 | $52.6M | Buy |
827,863
+42,863
| +5% | +$2.67M | 0.06% | 292 |
|
|
2025
Q3 | $43.1M | Buy |
785,000
+108,720
| +16% | +$4.48M | 0.11% | 201 |
|
|
2025
Q2 | $22.3M | Buy |
676,280
+153,812
| +29% | +$5.35M | 0.05% | 329 |
|
|
2025
Q1 | $21M | Buy |
522,468
+33,106
| +7% | +$1.52M | 0.06% | 331 |
|
|
2024
Q4 | $23M | Buy |
489,362
+161,290
| +49% | +$8.38M | 0.06% | 306 |
|
|
2024
Q3 | $17.3M | Sell |
328,072
-55,970
| -15% | -$3.12M | 0.04% | 333 |
|
|
2024
Q2 | $20.8M | Buy |
384,042
+29,544
| +8% | +$1.78M | 0.05% | 292 |
|
|
2024
Q1 | $24.9M | Sell |
354,498
-112,580
| -24% | -$8.71M | 0.07% | 275 |
|
|
2023
Q4 | $39M | Sell |
467,078
-149,400
| -24% | -$5.41M | 0.11% | 211 |
|
|
2023
Q3 | $18.2M | Buy |
616,478
+187,259
| +44% | +$6.24M | 0.06% | 306 |
|
|
2023
Q2 | $14M | Sell |
429,219
-135,533
| -24% | -$5.01M | 0.04% | 340 |
|
|
2023
Q1 | $19.9M | Sell |
564,752
-34,790
| -6% | -$1.42M | 0.07% | 293 |
|
|
2022
Q4 | $27.5M | Sell |
599,542
-29,257
| -5% | -$1.26M | 0.1% | 240 |
|
|
2022
Q3 | $30.5M | Sell |
628,799
-24,714
| -4% | -$1.19M | 0.12% | 199 |
|
|
2022
Q2 | $25.7M | Sell |
653,513
-139,643
| -18% | -$5.62M | 0.1% | 234 |
|
|
2022
Q1 | $29.2M | Sell |
793,156
-47,445
| -6% | -$1.69M | 0.1% | 239 |
|
|
2021
Q4 | $38.3M | Buy |
840,601
+18,854
| +2% | +$727K | 0.13% | 198 |
|
|
2021
Q3 | $29.4M | Sell |
821,747
-274,057
| -25% | -$8.07M | 0.11% | 223 |
|
|
2021
Q2 | $21.7M | Buy |
1,095,804
+189,082
| +21% | +$4.44M | 0.08% | 298 |
|
|
2021
Q1 | $21.1M | Buy |
906,722
+271,636
| +43% | +$5.8M | 0.09% | 270 |
|
|
2020
Q4 | $13.2M | Buy |
+635,086
| New | +$11.6M | 0.06% | 329 |
|
Other funds holding CYTK
VPM
VCM
ACA
